Glucose abnormalities in hepatitis C virus infection
Hepatitis C virus (HCV) infection is one of the most important causes of cirrhosis and hepatocellular carcinoma and has a tremendous impact on public health worldwide. HCV is both hepatotropic and lymphotropic. Replication of HCV in diseased extrahepatic organs and tissues may either trigger latent...
Main Authors: | Jee-Fu Huang, Ming-Lung Yu, Chia-Yen Dai, Wan-Long Chuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-02-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X12003294 |
Similar Items
-
Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
by: Sundaram V, et al.
Published: (2016-06-01) -
Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection
by: Rajiv Mehta, et al.
Published: (2017-03-01) -
Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients
by: Chen Z, et al.
Published: (2017-08-01) -
Latin American Association for the Study of the Liver Recommendations on Treatment of Hepatitis C
by: Nahum Méndez-Sánchez, et al.
Published: (2014-09-01) -
Efficacy of Combination Sofosbuvir, Pegylated-Interferon, and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 Infection in Indonesia
by: Andri Sanityoso Sulaiman, et al.
Published: (2018-08-01)